Medindia

X

IRIDEX Announces Fourth Quarter and Full Year 2009 Conference Call and Release Date

Friday, February 26, 2010 Corporate News J E 4
Advertisement

MOUNTAIN VIEW, Calif., Feb. 25 /PRNewswire-FirstCall/ -- áIRIDEX Corporation (Nasdaq: IRIX) today announced that it will release its fourth quarter and full year 2009 financial results after the market closes on Thursday, March 4, 2010. áIn conjunction with the release, the Company will host a conference call with the investment community at 5:00 p.m. Eastern Time on Thursday, March 4, 2010 to discuss the results of the quarter and full year and other business developments.

Interested parties may access the live conference call via telephone by dialing (877) 941-8609 U.S. or (480) 629-9818 (International) and quoting Conference ID 4244509, or by visiting the Company's website at www.iridex.com. áA telephone replay will be available beginning on Thursday, March 4, 2010 through Thursday, March 11, 2010 by dialing (800) 406-7325 (US) or (303) 590-3030 (International) and entering Access Code 4244509.

About IRIDEX

IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems and delivery devices. We provide solutions for multiple specialties, including ophthalmology, dermatology and otolaryngology. We maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. áIRIDEX is dedicated to a standard of excellence, offering superior technology for superior results. áIRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 100 independent distributors into 107 countries. áFor further information, visit the Company's website at http://www.iridex.com.

SOURCE IRIDEX Corporation

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
More Reliable Biomarkers Needed for Early Detectio...
S
Internal Anthem Blue Cross/WellPoint Document: Onl...